Results 91 to 100 of about 40,749 (237)

Significance of Hyperamylasaemia and Abdominal Pain in Diabetic Ketoacidosis [PDF]

, 1973
A H Knight, David N. Williams, Gregory Ellis, David M. Goldberg   +3 more
openalex   +1 more source

Highlighting the new consensus guidelines for managing people at risk of, and with early‐stage type 1 diabetes—Relevance to clinical care in the UK

Diabetic Medicine, EarlyView.
Parth Narendran, Philip Newland‐Jones, Naresh Kanumilli, Rose Stewart, Fiona Regan, Tabitha Randell   +5 more
wiley   +1 more source

Safety and clinical effectiveness of iGlarLixi in people with type 2 diabetes mellitus in Mexico

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate the safety and effectiveness of iGlarLixi in people with type 2 diabetes mellitus (T2DM) in clinical practice in Mexico. Materials and Methods This was a prospective, observational, multicentre study in adults with T2DM who were prescribed iGlarLixi in routine clinical practice in Mexico. The participants were followed for 24 ±
Juan Rosas‐Guzman, Alberto Navarro‐Lara, Maria Elena Sañudo‐Maury, Luis Anguiano, Leobardo Sauque‐Reyna   +4 more
wiley   +1 more source

Effect of sodium glucose cotransporter 2 inhibition immediately prior to heart transplantation

JHLT Open
Sodium glucose cotransporter 2 inhibitors (SGLT2i) are an established treatment for heart failure and type 2 diabetes. Guidelines suggest withholding SGLT2i preoperatively due to the risk of ketoacidosis.
Lisa M. Raven, MBBS, FRACP, Christopher A. Muir, MBBS (Hons), FRACP, PhD, Ricardo C. Deveza, MD, FRACP, Cassia Kessler Iglesias, MD (Hons), FRACP, Nicole K. Bart, MBBS (Hons), BSc (Med Sci), DPhil (Oxon), FRACP, Kavitha Muthiah, MBChB, PhD, FRACP, Eugene Kotlyar, MBBS, MD, MPVD, FRACP, Christopher S. Hayward, BMedSc, MBBS (Hons), MD, FRACP, Peter S. Macdonald, MBBS, MD, PhD, FRACP, Andrew Jabbour, BSc (Med), MBBS (Hons), PhD, FRACP, Jerry R. Greenfield, MBBS (Hons 1), PhD, FRACP   +10 more
doaj  

Global, regional and country‐specific burden of chronic kidney disease due to type 1 diabetes mellitus: A systematic analysis of the 2021 global disease burden study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Chronic kidney disease (CKD) affects individual welfare, healthcare systems and societal progress. Of the multifaceted etiological factors, type 1 diabetes mellitus (T1DM) is a prominent contributor to CKD. Materials and Methods We analysed the global incidence, prevalence, deaths and disability‐adjusted life‐years (DALYs) with age ...
Jianran Sun, Wan Hu, Shandong Ye, Min Xu, Datong Deng, Mingwei Chen   +5 more
wiley   +1 more source

The interplay between heart failure and chronic kidney disease

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Chronic kidney disease (CKD) and heart failure (HF) are two globally prevalent, independent, long‐term conditions, which often coexist in an individual and display a bidirectional yet interconnected relationship. The presence of CKD often leads to the development of HF and vice versa, which propagates the worsening of each disease, reflecting ...
Anuradha Lala, Adeera Levin, Kamlesh Khunti   +2 more
wiley   +1 more source

Evaluation of hyperglycaemic emergency admissions to a major tertiary centre over a two‐year period

Diabetic Medicine, EarlyView.
Serena Chong, Hannah Rubinstein, Tang Wong, Ann Poynten   +3 more
wiley   +1 more source

Illnesses associated with ketosis including diabetic ketoacidosis during very low carbohydrate and ketogenic diets. [PDF]

Diabetes Obes Metab
Abstract Aims Ketogenic diets are used by individuals with obesity and type 2 diabetes for improved glycaemic control, reduced appetite and weight loss. However, the risks associated with higher ketone levels, including diabetic ketoacidosis (DKA), in individuals with and without diabetes are not well‐documented.
Roberts CGP, Athinarayanan SJ, Ratner RE, Umpierrez GE.   +3 more
europepmc   +2 more sources

Letter: Diabetic ketoacidosis presenting as neurosurgical emergencies. [PDF]

, 1974
F E Preston, W R Timperley, J. D. Ward
openalex   +1 more source

Glucocorticoid‐induced hyperglycaemia in hospitalised adults: A matched cohort study (2013–2023)

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To compare the risk of new‐onset hyperglycaemia between inpatients treated versus non‐treated with systemic glucocorticoids and identify factors associated with glucocorticoid‐induced hyperglycaemia (GIH). Materials and methods We conducted a cohort study using electronic healthcare records of adults admitted to the Oxford University ...
Rajna Golubic, Hudson Mumbole, Ruth L. Coleman, Rustam Rea, Rohini Mathur, Rishi Caleyachetty, Amanda I. Adler   +6 more
wiley   +1 more source